Quick Answer
DiaMedica Therapeutics Inc. reported Shares Outstanding of 53.74 million shares for fiscal year 2025.
DiaMedica Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 53.74M | +25.5% |
| 2024 | 42.82M | +12.8% |
| 2023 | 37.96M | +43.5% |
| 2022 | 26.44M | +0.0% |
| 2021 | 26.44M | +41.1% |
| 2020 | 18.75M | +56.1% |
| 2019 | 12.01M | +0.4% |
| 2018 | 11.96M | +87.7% |
| 2017 | 6.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 52.08M | +21.8% | +20.9% |
| June 30, 2025 | 43.07M | +0.9% | +0.5% |
| March 31, 2025 | 42.86M | +12.9% | +0.1% |
| December 31, 2024 | 42.82M | +12.8% | +0.1% |
| September 30, 2024 | 42.77M | +12.7% | +0.2% |
| June 30, 2024 | 42.69M | +12.5% | +12.5% |
| March 31, 2024 | 37.96M | +43.4% | +0.0% |
| December 31, 2023 | 37.96M | +43.5% | +0.0% |
- DiaMedica Therapeutics Inc. showed an increase of +25.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, DiaMedica Therapeutics Inc.’s shares outstanding has grown by 743.6% (from 6.37 million shares to 53.74 million shares).
- The most recent figure is from DiaMedica Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: